Gautam Borthakur, Michael G. Rosenblum, Moshe Talpaz, Naval Daver, Farhad Ravandi, Stefan Faderl, Emil J. Freireich, Tapan Kadia, Guillermo Garcia-Manero, Hagop Kantarjian, and Jorge E. Cortes. 2013. “Phase 1 Study of an Anti-CD33 Immunotoxin, Humanized Monoclonal Antibody M195 Conjugated to Recombinant Gelonin (HUM-195/RGEL), in Patients With Advanced Myeloid Malignancies”. Haematologica 98 (2). Pavia, Italy, 217-21. https://doi.org/10.3324/haematol.2012.071092.